Vasopressor Management by Shock Type

Overview of Vasopressor Selection

The choice of vasopressor depends critically on the underlying shock mechanism, with norepinephrine serving as first-line for most shock states except hypovolemic shock where volume restoration takes absolute priority 1, 2

Vasopressors are NOT the primary treatment for hypovolemic shock—aggressive fluid resuscitation with balanced crystalloids is the definitive therapy 1, 2
Immediate fluid resuscitation with isotonic crystalloids is the cornerstone of treatment 1, 2
Vasopressors may be used transiently only in life-threatening hypotension while simultaneously achieving hemorrhage control and volume restoration 1
The primary goal is restoration of intravascular volume and definitive control of bleeding—vasopressors are a temporizing bridge only 1

Norepinephrine is the vasopressor of choice for most patients with cardiogenic shock, particularly those with tachycardia, as it causes fewer arrhythmias than alternatives 1
Norepinephrine is the preferred agent based on randomized trial data showing improved survival and fewer arrhythmias compared to dopamine 1
Inotropes (dobutamine or milrinone) are first-line when hypotension occurs with low cardiac output in acute heart failure 1, 2
Persistently hypotensive with tachycardia: Use norepinephrine 1, 2
Bradycardia present: Consider dopamine 1, 2
Afterload-dependent states (aortic stenosis, mitral stenosis): Use phenylephrine or vasopressin 2
Low cardiac output with adequate preload: Add dobutamine (up to 20 μg/kg/min) to norepinephrine 1

Norepinephrine is the first-line vasopressor for distributive shock after adequate fluid resuscitation, with vasopressin added as a second agent if hypotension persists 2
Norepinephrine is recommended as the initial vasopressor after appropriate fluid resuscitation with balanced crystalloids 2
Target MAP ≥65 mmHg as the standard goal, though this should be individualized based on baseline blood pressure and comorbidities 4
Vasopressin (up to 0.03 units/min) should be added if hypotension persists despite norepinephrine 2, 4
Add dobutamine to norepinephrine when there is evidence of myocardial dysfunction with elevated filling pressures and low cardiac output 2, 4

Early vasopressor use reduces organ failure incidence 3
Vasopressors may be initiated during fluid resuscitation and weaned as tolerated 1
Arterial catheter placement should occur as soon as practical in all patients requiring vasopressors 3
Adequate fluid resuscitation must precede or accompany vasopressor therapy in hypovolemic, cardiogenic, and obstructive shock where decreased cardiac output is the primary problem 1, 2